Mira Woitok
Aachen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comparison of a mouse and a novel human scFv-SNAP-auristatin F drug conjugate with potent activity against EGFR-overexpressing human solid tumor cells.
Journal: OncoTargets and therapy
Published: July 26, 2017
Efficient targeting of CD13 on cancer cells by the immunotoxin scFv13-ETA' and the bispecific scFv [13xds16].
Journal: Journal of cancer research and clinical oncology
Published: May 18, 2017
Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins.
Journal: PloS one
Published: December 11, 2016
Fine Tuning Antibody Conjugation Methods using SNAP-tag Technology.
Journal: Anti-cancer agents in medicinal chemistry
Published: August 03, 2016
The efficient elimination of solid tumor cells by EGFR-specific and HER2-specific scFv-SNAP fusion proteins conjugated to benzylguanine-modified auristatin F.
Journal: Cancer letters
Published: June 07, 2016
CD64-directed microtubule associated protein tau kills leukemic blasts ex vivo.
Journal: Oncotarget
Published: March 14, 2016
A novel fully-human cytolytic fusion protein based on granzyme B shows in vitro cytotoxicity and ex vivo binding to solid tumors overexpressing the epidermal growth factor receptor.
Journal: Cancer letters
Published: December 10, 2015
A specific photoimmunotheranostics agent to detect and eliminate skin cancer cells expressing EGFR.
Journal: Journal of cancer research and clinical oncology
Published: May 12, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026